Rubius Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
27 Feb 2023	Form 4: Appelhans Dannielle, CEO and President Sold 10,385 shares ($1.32K)
01 Feb 2023	Form 4: Cagnoni Pablo J, Director Sold 8,448 shares ($2.11K)
01 Feb 2023	Form 4: Appelhans Dannielle, CEO and President Received 7,500 shares by exercise or conversion · Sold 3,878 shares ($970)
31 Jan 2023	Form 4: Cagnoni Pablo J, Director Received 21,250 shares by exercise or conversion · Received 25,000 shares by exercise or conversion · Sold 7,240 shares ($1.74K)
31 Jan 2023	Form 4: Turka Laurence A., Chief Scientific Officer Received 7,438 shares by exercise or conversion · Received 8,625 shares by exercise or conversion · Sold 2,593 shares ($622)
12 Aug 2022	Form 4: Appelhans Dannielle, Chief Operating Officer Received 12,500 shares by exercise or conversion · Sold 5,737 shares ($4.59K)
01 Aug 2022	Form 4: Schaffert Susanne, Director Granted 50,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Prener Anne, Director Granted 25,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Holles Natalie C., Director Granted 25,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Cuss Francis M, Director Granted 25,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Rosenblatt Michael, Director Granted 25,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Sohn Catherine A., Director Granted 25,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Afeyan Noubar, Director Granted 25,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Symonds Jonathan, Director Granted 25,000 Stock Option (Right to Buy)
13 May 2022	Form 4: Epstein David R, Director Granted 499,762 Stock Option (Right to Buy)
22 Apr 2022	Form 4: Epstein David R, Director Bought 30,000 shares ($43.3K)
01 Feb 2022	Form 4: Cagnoni Pablo J, Director Received 21,250 shares by exercise or conversion · Granted 365,000 Stock Option (Right to Buy) · Granted 100,000 Restricted Stock Units · 1 more
01 Feb 2022	Form 4: Carmona Jose, Chief Financial Officer Granted 143,750 Stock Option (Right to Buy) · Granted 34,500 Restricted Stock Units
01 Feb 2022	Form 4: Appelhans Dannielle, Chief Operating Officer Granted 125,000 Stock Option (Right to Buy) · Granted 30,000 Restricted Stock Units
01 Feb 2022	Form 4: Keson-Brookes Maiken, CLO & Corp. Secretary Received 8,075 shares by exercise or conversion · Granted 143,750 Stock Option (Right to Buy) · Granted 34,500 Restricted Stock Units · 1 more

Comments